Table 1 Patient characteristics.
From: The use of biological amniotic membranes in the treatment of recurrent macular holes
Patient | Sex/age (years) | Eye | Axial length (mm) | MH (μm) | Posterior scleral staphyloma | Surgery (times) | Pre-BCV A (logMAR) | Post-BCVA (logMAR) | Pre-IOP (mmHg) | Post-IOP (mmHg) | MH status |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F/57 | L | 27.2 | 732 | NO | 2 | 1.6 | 1.1 | 30 | 20.9 | Closed |
2 | F/61 | L | 28.1 | 636 | NO | 3 | 1.5 | 1.0 | 17.3 | 16 | Closed |
3 | F/66 | L | 29.3 | 1561 | YES | 3 | 1.7 | 1.7 | 18.9 | 17.2 | Closed |
4 | M/65 | R | 27 | 1489 | NO | 2 | 2.5 | 2.5 | 16.5 | 16.2 | Closed |
5 | M/54 | R | 28.1 | 634 | NO | 2 | 1.4 | 0.6 | 28.1 | 17 | Closed |
6 | F/70 | L | 27 | 567 | NO | 3 | 1.7 | 1.3 | 27.6 | 18 | Closed |
7 | F/69 | R | 28.1 | 598 | NO | 2 | 2 | 1.2 | 27.8 | 17.1 | Closed |
8 | M/56 | L | 26.9 | 672 | NO | 3 | 1.2 | 0.7 | 19.6 | 16.5 | Closed |
9 | F/59 | R | 28.3 | 702 | YES | 2 | 1.7 | 1.3 | 15 | 17.2 | Closed |
10 | M/61 | L | 27 | 498 | NO | 3 | 1.7 | 1.1 | 14.7 | 14.8 | Closed |
11 | F/63 | R | 28.3 | 477 | YES | 4 | 2 | 1.2 | 17.2 | 16.3 | Closed |
12 | F/65 | L | 28.4 | 872 | YES | 2 | 2.5 | 1.6 | 29.1 | 19.3 | Closed |
13 | M/59 | L | 28.6 | 912 | YES | 2 | 1.6 | 0.8 | 28.4 | 17 | Closed |
14 | M/54 | L | 27.8 | 813 | NO | 2 | 1.6 | 0.9 | 20.1 | 19 | Closed |
15 | F/48 | R | 27.5 | 752 | NO | 3 | 1.4 | 1.0 | 21 | 16.2 | Closed |
16 | M/49 | R | 27.5 | 783 | NO | 2 | 1.5 | 0.6 | 19 | 18.2 | Closed |
17 | F/61 | R | 26.8 | 691 | NO | 3 | 2 | 0.9 | 17.8 | 16.3 | Closed |
18 | F/63 | L | 28.7 | 761 | YES | 2 | 1.6 | 0.9 | 18.3 | 16.2 | Closed |
19 | M/55 | R | 28.2 | 594 | NO | 3 | 1.7 | 0.8 | 25.8 | 19 | Closed |
20 | M/70 | L | 26.4 | 690 | NO | 2 | 2 | 1.4 | 29.4 | 17.4 | Closed |
21 | F/67 | L | 29.1 | 677 | YES | 2 | 1.6 | 0.8 | 16.7 | 15 | Closed |
22 | M/68 | L | 26.9 | 856 | NO | 2 | 1.5 | 1.1 | 19.6 | 14.6 | Closed |
23 | M/59 | R | 27.1 | 734 | NO | 2 | 1.7 | 1.2 | 31 | 21 | Closed |
